http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03017938-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70126af1ffd0e84da8c091b6ee0879b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed81c6ea93edb0d59f9c35d7a9c6cd52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 2002-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb49dba27755793c8304b0a66bf4f965 |
| publicationDate | 2003-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-03017938-A2 |
| titleOfInvention | Conjugates targeted to target receptors |
| abstract | The present invention provides conjugates that preferentially bind to or otherwise associate with specific target cells and methods for using such compositions. Specifically, the present invention provides conjugates comprising a pendant polyalkylene glycol, and a ligand comprising a peptide that preferentially binds to or otherwise associates with a target-receptor. The present invention also provides methods for detecting a disease using such conjugates. In addition, the present invention provides methods for delivering chemical agents and drugs to a mammal using the conjugates of the invention. |
| priorityDate | 2001-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 335.